Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) currently has a daily average trading volume of 1.07M but it saw 1815186 shares traded in last market. With a market cap of 3.73B USD, the company’s current market price of $39.46 came rising about 8.83 while comparing to the previous closing price of $36.26. In past 52 weeks, the stock remained buoying in the range of price level as high as $60.37 and as low as $29.59. In the recent trading on the day, stock has struck highest price mark of $36.48 while lowest mark touched by it was $39.87.
Goldman upgraded its recommendation for the stock as a “Buy” from “Neutral” on June 06, 2024 while assigning a price target range of $56-$67. RBC Capital Mkts also issued its recommendations for the stock as it initiated the price target for the stock is $77.
Over the week, RARE’s stock price is moving 5.42% up while it is 9.19% when we observe its performance for the past one month. Year-to-date it is -3.99% down and over the past year, the stock is showing a downside performance of -6.20%.
Currently, Ultragenyx Pharmaceutical Inc’s total number of outstanding shares is 93.74M with 3.20% of that held by the insiders while 98.45% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -56.89% and return on equity (ROE) at -386.33%. Stock’s beta reads 0.26. Stock has a price to book (P/B) ratio of 25.64 while price to sale or P/S ratio amounts to 6.32. Its return on asset (ROA) is -41.97% on average.
#
